AI / data analytics / healthtech / informatics

#AI / data analytics / healthtech / informatics #Antibodies #Biotech #Drug discovery #GLP-1 #IPO #Mergers and acquisitions #Neuroscience

JPM 2026: Less talk and more action 

‘JPM 2026’ certainly felt different to recent editions of the conference. The sky was blue – and the XBI had nearly doubled over the previous nine months.  There’s nothing like a little winter sun and booming stocks to put a spring in an executive’s step!  But questions over the robustness of the biopharma sector remain – to be expected after… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Alzheimer's #Drug discovery #Oncology #Regulatory #Spatial biology

DDW Winter issue out now

The DDW Winter 2025/2026 issue is out now and includes features covering the advances and challenges in blood cancer drug development, how the Baltics is implementing a new action plan for its life sciences sectors, and how spatial epigenetics is unlocking new frontiers for drug discovery.  It also… Read More

#News

2026 ideas
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Machine learning

2026: An AI tipping point for drug discovery

How big a role will AI play in the coming year? Diana Turner asks industry leaders for their predictions. As with all sectors, the role of artificial intelligence (AI) in drug discovery is expected to significantly increase in 2026 and beyond. Richard Young, CSO at CluePoints, explains: “The industry will… Read More

#Exclusive Content #Trends & Analysis

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Webinar

Register now: Get an inside view of AI-native science in action

This webinar, sponsored by Benchling, provides an exclusive readout of what biotech leaders need to know heading into 2026 — and how 100 AI frontrunners are translating AI into real scientific impact. Get a rare, upfront look at what the most advanced biotech teams are actually… Read More

Webinar date:
Supported by Benchling
#News

Artificial Intelligence
#AI #AI / data analytics / healthtech / informatics #Drug discovery

Insitro acquires AI biotech to develop drug discovery platform 

AI therapeutics company insitro has acquired biotechnology company CombinAbleAI to complete its AI platform for drug discovery and design.   The platform, known as TherML (Therapeutic Machine Learning), will enable insitro to accelerate the generation of clinic-ready assets and reduce late-stage development risk. The company’s enhanced platform will reportedly guide both modality selection and molecular design from target discovery through developability assessment.  "Drug discovery has traditionally… Read More

#Business & Investment #News

AI roadmap
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Webinar

Register now: The next wave of AI in biotech

This webinar, sponsored by Benchling, provides an exclusive readout of what biotech leaders need to know heading into 2026 — and how 100 AI frontrunners are translating AI into real scientific impact. Get a rare, upfront look at what the most advanced biotech teams are actually… Read More

Webinar date:
Supported by Benchling
#News

Therapeutic antibodies
#Absci #AI #AI / data analytics / healthtech / informatics #Antibody-based therapeutics #Biologics #Generative AI #Machine learning

How the next generation of AI is reshaping antibody drug discovery

This is the latest episode of the free DDW Narrated Podcast. The episode covers two articles written for DDW Volume 25, Issue 2, Spring 2024. The first article is called ‘Machine learning: developing next generation antibody therapeutics’. Ben Holland, CTO and Co-Founder of Antiverse, discusses how artificial intelligence and… Read More

#Featured Podcasts #Podcasts

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Webinar

Webinar: Where is AI delivering measurable gains for drug discovery?

This webinar, sponsored by Benchling, provides an exclusive readout of what biotech leaders need to know heading into 2026 — and how 100 AI frontrunners are translating AI into real scientific impact. Get a rare, upfront look at what the most advanced biotech teams are actually… Read More

Webinar date:
Supported by Benchling
#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Webinar

How are companies translating AI into real scientific impact?

This webinar, sponsored by Benchling, provides an exclusive readout of what biotech leaders need to know heading into 2026 — and how 100 AI frontrunners are translating AI into real scientific impact. Get a rare, upfront look at what the most advanced biotech teams are actually… Read More

Webinar date:
Supported by Benchling
#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Biomedical research #Drug repurposing

What else can AI fix? Applications in indication expansion and repurposing

Ben Sidders, Chief Scientific Officer at Biorelate, explores how emerging AI-driven technologies are revealing hidden cause-and-effect relationships within existing biomedical data.  Nearly 30% of FDA-approved drugs eventually gain additional indications beyond their original approval and are some of the highest-value and most challenging assessments in drug development. Indication expansion is… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Webinar

Webinar: The power shift shaping biotech’s AI future

This webinar, sponsored by Benchling, provides an exclusive readout of what biotech leaders need to know heading into 2026 — and how 100 AI frontrunners are translating AI into real scientific impact. Get a rare, upfront look at what the most advanced biotech teams are actually… Read More

Webinar date:
Supported by Benchling
#News

AI and genomics
#AI / data analytics / healthtech / informatics #Genetics / genomics #Genomics #Market reporting

How are innovations in genomics redefining drug discovery?

Advances in artificial intelligence and synthetic biology are driving a new frontier in genomic research. Megan Thomas explores what the future of genomics will look like. New technologies for the future In a Eureka! podcast interview with McKinsey, Howard Jacob, Vice President of Genomics Research and Head of Data Integration… Read More

#Exclusive Content #Market Reports

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Webinar

The 2026 Biotech AI Report: Breakthroughs, bottlenecks, and the power shift shaping biotech’s AI future

This webinar, sponsored by Benchling, provides an exclusive readout of what biotech leaders need to know heading into 2026 — and how 100 AI frontrunners are translating AI into real scientific impact. Get a rare, upfront look at what the most advanced biotech teams are actually… Read More

Webinar date:
Supported by Benchling
#Webinars

#AI / data analytics / healthtech / informatics #Automation #Drug discovery #Organoids #Webinar

Webinar: Overcome organoid workflow challenges with AI

Hosted by Drug Discovery World and supported by Galatek, this webinar explores how automation and AI enable reliable, scalable models by standardising organoid workflows. Organoids have emerged as powerful in vitro models in disease modelling, drug screening, and regenerative medicine, but their complexity introduces major workflow… Read More

Webinar date:
Supported by Galatek
#News

#AI / data analytics / healthtech / informatics #Automation #Drug discovery #Organoids #Webinar

Webinar: How automation and AI can standardise organoid workflows

Hosted by Drug Discovery World and supported by Galatek, this webinar explores how automation and AI enable reliable, scalable models by standardising organoid workflows. Organoids have emerged as powerful in vitro models in disease modelling, drug screening, and regenerative medicine, but their complexity introduces major workflow… Read More

Webinar date:
Supported by Galatek
#News

Robotic arm, automation
#AI / data analytics / healthtech / informatics #Automation #Drug discovery #Organoids #Webinar

Webinar: Overcome organoid workflow challenges with automation

Hosted by Drug Discovery World and supported by Galatek, this webinar explores how automation and AI enable reliable, scalable models by standardising organoid workflows. Organoids have emerged as powerful in vitro models in disease modelling, drug screening, and regenerative medicine, but their complexity introduces major workflow… Read More

Webinar date:
Supported by Galatek
#News